Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting

Sarah M. Hicks, Kai Pohl, Teresa Neeman, Hayley A. McNamara, Kate M. Parsons, Jin-shu He, Sidra A. Ali, Samina Nazir, Louise C. Rowntree, Thi H. O. Nguyen, Katherine Kedzierska, Denise L. Doolan, Carola G. Vinueas, Matthew C. Cook, Nicholas Coatsworth, Paul S. Myles, View ORCID ProfileFlorian Kurth, Leif E. Sander, Graham J. Mann, Russell L. Gruen, Amee J. George, Elizabeth E. Gardiner, View ORCID ProfileIan A. Cockburn, the SARS-CoV-2 Testing in Elective Surgery Collaborators
doi: https://doi.org/10.1101/2020.09.09.20191031
Sarah M. Hicks
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Pohl
2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
3Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Neeman
4Biological Data Science Institute, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayley A. McNamara
2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate M. Parsons
5ANU Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-shu He
5ANU Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sidra A. Ali
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samina Nazir
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise C. Rowntree
6Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thi H. O. Nguyen
6Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Kedzierska
6Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise L. Doolan
7Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carola G. Vinueas
2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
8China Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Jiaotong University, Shanghai, China
9Department of Immunology Canberra Hospital, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew C. Cook
2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
9Department of Immunology Canberra Hospital, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Coatsworth
10ANU Medical School, Australian National University, Canberra, Australia
11The Canberra Hospital, Infectious Diseases, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul S. Myles
12Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Australia
13Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Kurth
3Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Florian Kurth
Leif E. Sander
3Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham J. Mann
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell L. Gruen
14College of Health and Medicine, Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amee J. George
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
5ANU Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth E. Gardiner
1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian A. Cockburn
2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian A. Cockburn
  • For correspondence: ian.cockburn@anu.edu.au
15See Supplementary Text
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Estimates of seroprevalence of SARS-CoV-2 antibodies have been hampered by inadequate assay sensitivity and specificity. Using an ELISA-based approach to that combines data about IgG responses to both the Nucleocapsid and Spike-receptor binding domain antigens, we show that near-optimal sensitivity and specificity can be achieved. We used this assay to assess the frequency of virus-specific antibodies in a cohort of elective surgery patients in Australia and estimated seroprevalence in Australia to be 0.28% (0 to 0.72%). These data confirm the low level of transmission of SARS-CoV-2 in Australia before July 2020 and validate the specificity of our assay.

Competing Interest Statement

NC is an employee of the Australian Government Department of Health and Ageing contributed to study design, interpretation of results, and approval of the manuscript. All other authors declare no competing interests.

Funding Statement

The study was sponsored by the Australian Government Department of Health and Ageing and Medibank Private.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Collection of blood from individuals pre-2020 was carried out after provision of informed consent, using procedures approved by the Human Research Ethics Committees (HREC) of the Australian National University (2016/317) and ACT Health (1.16.011 and 1.15.015). Samples from SARS-CoV-2 positive individuals were collected after consent under the following protocols: Alfred Hospital HREC (280/14); James Cook University HREC (#H7886); ACT Health HREC (1.16.011): Charite Ethics Committee (EA2/066/20) [7]. Approval for the elective surgery study was given by Alfred Hospital Ethics Committee (339/20) and the Australian National University (2020/379).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflicts of Interest Statement: NC is an employee of the Australian Government Department of Health and Ageing contributed to study design, interpretation of results, and approval of the manuscript. All other authors declare no competing interests.

  • Funding: The study was sponsored by the Australian Government Department of Health and Ageing and Medibank Private.

Data Availability

All data pertaining to this paper is reported in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting
Sarah M. Hicks, Kai Pohl, Teresa Neeman, Hayley A. McNamara, Kate M. Parsons, Jin-shu He, Sidra A. Ali, Samina Nazir, Louise C. Rowntree, Thi H. O. Nguyen, Katherine Kedzierska, Denise L. Doolan, Carola G. Vinueas, Matthew C. Cook, Nicholas Coatsworth, Paul S. Myles, Florian Kurth, Leif E. Sander, Graham J. Mann, Russell L. Gruen, Amee J. George, Elizabeth E. Gardiner, Ian A. Cockburn, the SARS-CoV-2 Testing in Elective Surgery Collaborators
medRxiv 2020.09.09.20191031; doi: https://doi.org/10.1101/2020.09.09.20191031
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting
Sarah M. Hicks, Kai Pohl, Teresa Neeman, Hayley A. McNamara, Kate M. Parsons, Jin-shu He, Sidra A. Ali, Samina Nazir, Louise C. Rowntree, Thi H. O. Nguyen, Katherine Kedzierska, Denise L. Doolan, Carola G. Vinueas, Matthew C. Cook, Nicholas Coatsworth, Paul S. Myles, Florian Kurth, Leif E. Sander, Graham J. Mann, Russell L. Gruen, Amee J. George, Elizabeth E. Gardiner, Ian A. Cockburn, the SARS-CoV-2 Testing in Elective Surgery Collaborators
medRxiv 2020.09.09.20191031; doi: https://doi.org/10.1101/2020.09.09.20191031

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8985)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1957)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10808)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (998)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1902)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (548)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)